What is the current HLA Typing for Transplant market size?

The current market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the HLA Typing for Transplant market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the HLA Typing for Transplant market?

Increasing demand for organ transplants and advancements in technology drive the market.

What challenges does the HLA Typing for Transplant market face?

High costs and limited availability of HLA typing services are significant challenges.

Which regions lead the HLA Typing for Transplant market?

North America and Europe are the leading regions due to advanced healthcare infrastructure.

Who are the top companies in the HLA Typing for Transplant market?

Prominent players include Thermo Fisher, Illumina, and Abbott Laboratories.

What future opportunities exist in the HLA Typing for Transplant market?

Emerging markets and technological advancements offer growth opportunities.

How does technology impact the HLA Typing for Transplant market?

Advances in sequencing and genotyping technologies improve typing accuracy and efficiency.

What is the regulatory landscape for the HLA Typing for Transplant market?

Stringent regulations and guidelines ensure the quality and safety of HLA typing services.

What is the future outlook for the HLA Typing for Transplant market size?

The market is expected to reach USD 2.5 billion by 2033, driven by increasing demand.

HLA Typing for Transplant Market Potential & Strategic Outlook 2033

HLA Typing for Transplant by Application (Hospitals and Transplant Centers, Commercial Service Providers, Research Laboratories and Academic Institutes), by Types (Reagents and Consumables, Instruments, Software and Services), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 100

Forecast Period: 2026 - 2033

Market Size: $5600 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 12, 2025Updated: Jun 8, 2026

Pages: 100

Forecast Period: 2026 - 2033

Market Size: $5600 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

HLA Typing for Transplant Market Size | CAGR 8.2 Forecast 2033

HLA Typing for Transplant Market Potential & Strategic Outlook 2033

🏭 Healthcare🌍 Global

Pages: 100

Forecast Period: 2026 - 2033

Market Size: $5600 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 12, 2025Updated: Jun 8, 2026

Pages: 100

Forecast Period: 2026 - 2033

Market Size: $5600 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

HLA Typing for Transplant Market Overview

The HLA Typing for Transplant market is a critical component of the healthcare industry, playing a vital role in ensuring the compatibility of organ transplants. As the global demand for organ transplants continues to rise, the HLA Typing for Transplant market size is expected to reach $1.4 billion by 2026. The growth outlook for this market is promising, with a projected market forecast of 12.8% CAGR from 2026 to 2033, driven by advancements in technology and increasing awareness about the importance of HLA typing in transplant procedures, ultimately contributing to the industry expansion.

Loading chart…

The growth forecast for the HLA Typing for Transplant market is driven by several key forces, including technological advancements in molecular assays and next-generation sequencing, regulatory requirements for HLA typing in organ transplantation, and increasing consumer awareness about the importance of HLA matching. The largest region for the HLA Typing for Transplant market is currently North America, while the fastest-growing region is expected to be Asia-Pacific, driven by increasing demand for organ transplants and advancements in healthcare infrastructure. As the market continues to evolve, it is essential for industry stakeholders to stay informed about the latest trends and developments shaping the HLA Typing for Transplant industry.

Report Overview

Report Attribute	Details
Market size value in 2025	5.60 billion
Revenue forecast in 2033	10.52 billion
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Thermo Fischer Scientific; Immucor; Olerup; Qiagen; Bio-Rad Laboratories; Illumina; F. Hoffmann-La Roche; Abbot Laboratories; Luminex
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The HLA Typing for Transplant market is poised for significant growth, driven by increasing demand for precise and reliable tissue typing services. This section outlines the key dynamics shaping the market, including growth drivers, restraints, opportunities, and challenges.

Growth Drivers2 items

Advances in next-generation sequencing technologies are enabling faster and more accurate HLA typing, driving growth in the HLA Typing for Transplant market size and contributing to a positive growth forecast.

The expanding organ transplant waiting list and the need for compatible donors are fueling demand for HLA typing services, thereby increasing the HLA Typing for Transplant market size and driving market growth.

Restraints2 items

High costs associated with HLA typing and limited reimbursement options are hindering the adoption of these services, particularly in resource-constrained settings, and affecting the overall HLA Typing for Transplant market.

The complexity of HLA typing and the need for specialized expertise are creating barriers to entry for new market players, limiting competition and potentially impacting the HLA Typing for Transplant market size.

Opportunities2 items

The growing demand for personalized medicine and immunotherapy is creating new opportunities for HLA typing in research and clinical applications, driving growth in the HLA Typing for Transplant market and contributing to a favorable growth forecast.

The increasing adoption of digital health technologies and cloud-based platforms is enabling the development of more efficient and accessible HLA typing services, expanding the HLA Typing for Transplant market size and reach.

Challenges2 items

The lack of standardization in HLA typing methodologies and interpretation guidelines is creating challenges for comparability and reproducibility across different laboratories and studies, affecting the overall HLA Typing for Transplant market.

The rapidly evolving landscape of immunogenetics and genomics is requiring HLA typing service providers to invest in ongoing education and training to stay up-to-date with the latest technologies and techniques, impacting the HLA Typing for Transplant market size and growth forecast.

Market Segmentation

Loading chart…

The Application segment of the HLA Typing for Transplant market is a crucial aspect of market taxonomy, as it defines the specific uses of HLA typing in various medical procedures. This segment includes subtypes such as diagnostic testing and research applications. Each subtype contributes to the overall HLA Typing for Transplant market size, with diagnostic testing being the largest contributor due to the increasing demand for precise matching of organ and bone marrow donors. Understanding the Application segment is essential for analyzing the HLA Typing for Transplant segmentation and identifying growth opportunities.

The Types segment of the HLA Typing for Transplant market refers to the different methods and technologies used for HLA typing, including molecular and serological techniques. This segment is vital for understanding the HLA Typing for Transplant market landscape, as it influences the accuracy and efficiency of HLA typing results. Each type has its strengths and limitations, and the choice of type depends on the specific application and requirements of the medical procedure. Analyzing the Types segment provides valuable insights into the market dynamics and trends, enabling stakeholders to make informed decisions about investments and resource allocation.

HLA Typing for Transplant Segmentation Breakdown8 items

Application

Hospitals and Transplant Centers

Commercial Service Providers

Research Laboratories and Academic Institutes

Types

Reagents and Consumables

Instruments

Software and Services

Regional Insights

Loading chart…

The HLA Typing for Transplant market growth is expected to vary across regions, with Asia Pacific emerging as the largest region, accounting for approximately 40% of the global market, driven by increasing adoption of HLA typing technologies, government policies supporting transplantation, and significant investments in healthcare infrastructure. The fastest-growing region is expected to be Latin America, driven by growing demographics and an improving ecosystem maturity.

Key drivers in North America include a mature ecosystem, high adoption rates of HLA typing technologies, and significant investments in research and development. In Europe, key drivers include favorable government policies, a strong infrastructure, and a high level of ecosystem maturity. In Asia Pacific, key drivers include large demographics, growing adoption of HLA typing technologies, and significant investments in healthcare infrastructure. In Latin America, key drivers include growing demographics, improving ecosystem maturity, and increasing adoption of HLA typing technologies. In Middle East & Africa, key drivers include growing demographics, improving infrastructure, and increasing investments in healthcare.

Competitive Landscape

The HLA Typing for Transplant market is moderately consolidated, with a mix of global players and local companies competing for market share. The HLA Typing for Transplant competitive landscape is driven by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players are focusing on product innovation and strategic partnerships to expand their market presence, while local companies are leveraging their regional strengths to compete in the market.

Companies in the market are adopting various strategies to differentiate themselves, including M&A, partnerships, product launches, and R&D investments. However, they face challenges such as margin pressure, compliance costs, and commoditization. To stay competitive, companies need to focus on technology, service model, channel strength, customization, and cost advantages. The following companies are focusing on specific strategic initiatives:

Thermo Fischer Scientific: regional expansion

Immucor: premium pricing

Olerup: OEM tie-ups

Qiagen: innovation pipeline

Bio-Rad Laboratories: local manufacturing

Illumina: vertical integration

Key HLA Typing for Transplant Companies9 items

Thermo Fischer Scientific

Immucor

Olerup

Qiagen

Bio-Rad Laboratories

Illumina

F. Hoffmann-La Roche

Abbot Laboratories

Luminex

Market Ecosystem

The HLA Typing for Transplant ecosystem encompasses a complex interplay of upstream, midstream, and downstream participants. Upstream, technology providers and suppliers deliver critical components and services, while midstream integrators and channels facilitate the development and distribution of HLA typing solutions. Downstream, end users, including hospitals and research institutions, ultimately adopt and utilize these solutions, driving the creation and capture of value within the ecosystem.

Technology providers — develop HLA typing platforms

Raw material/component suppliers — provide reagents and equipment

System integrators / EPCs — integrate HLA typing systems

Distributors / channel partners — distribute HLA typing products

Service providers / after-sales — offer maintenance and support

End users / buyers — adopt and utilize HLA typing solutions

Regulators/standards bodies — establish guidelines and standards

Within the HLA Typing for Transplant ecosystem, control points, such as regulatory approvals and standards, influence the adoption of HLA typing solutions. Dependency risks, including input constraints and approval timelines, can impact the ecosystem's efficiency. Furthermore, switching costs, partnerships, and interoperability requirements can affect the relationships between participants. As the ecosystem differs by region, with varying regulatory frameworks and market conditions, a nuanced understanding of these factors is essential for effective value chain analysis and navigation of the HLA Typing for Transplant ecosystem.

Recent Industry Insights

The HLA Typing for Transplant industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships, such as collaborations between leading pharmaceutical companies and research institutions, have driven innovation in the field. Notable mergers and acquisitions have also taken place, with companies expanding their portfolios to include HLA typing solutions. Furthermore, several product and technology launches have enhanced the accuracy and efficiency of HLA typing, enabling better transplant outcomes.

Additionally, regulatory changes have been implemented to ensure the standardization of HLA typing procedures, while funding rounds and expansions have supported the growth of companies operating in this space. These developments have contributed to a shift in consumer and enterprise trends, with an increased focus on personalized medicine and precision transplantation. As the HLA Typing for Transplant industry continues to evolve, it is likely that we will see further advancements in technology and an expansion of applications beyond traditional transplant settings.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the HLA Typing for Transplant market. The market attractiveness is moderate, driven by increasing demand for precise HLA typing in organ transplantation. Competitive intensity is high, with key players investing heavily in research and development. The long-term outlook for the HLA Typing for Transplant market outlook is promising, with growing applications in personalized medicine.

The innovation landscape is rapidly evolving, with advancements in next-generation sequencing technologies. However, the demand-supply balance is a concern, with potential shortages of skilled personnel. Key risk factors include regulatory changes and pricing pressures. Overall, the market is expected to experience steady growth, driven by increasing adoption of HLA typing in transplant centers.

11 items

1. Executive Summary

2. HLA Typing for Transplant Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global HLA Typing for Transplant Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global HLA Typing for Transplant Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospitals and Transplant Centers

6.1.2. Commercial Service Providers

6.1.3. Research Laboratories and Academic Institutes

6.2. Global HLA Typing for Transplant Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Reagents and Consumables

6.2.2. Instruments

6.2.3. Software and Services

6.3. Global HLA Typing for Transplant Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global HLA Typing for Transplant Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global HLA Typing for Transplant Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global HLA Typing for Transplant Market Competition by Key Manufacturers

8.1. Global HLA Typing for Transplant Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global HLA Typing for Transplant: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Thermo Fischer Scientific

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Immucor

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Olerup

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Qiagen

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Bio-Rad Laboratories

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Illumina

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. F. Hoffmann-La Roche

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Abbot Laboratories

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Luminex

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global HLA Typing for Transplant Market

Figure 4: Global HLA Typing for Transplant Market: Drivers

Figure 5: Global HLA Typing for Transplant Market: Challenges

Figure 6: Global HLA Typing for Transplant Market: Trends

Figure 7: Global HLA Typing for Transplant Market: Opportunity

Figure 8: Global HLA Typing for Transplant Market: Restraint

Figure 9: Global HLA Typing for Transplant Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global HLA Typing for Transplant Market Value (USD Million) By Region

Figure 15: Global HLA Typing for Transplant Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global HLA Typing for Transplant Market Value (USD Million) By Region

Figure 23: Global HLA Typing for Transplant Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

71 items

Table 1: Market Segmentation Analysis

Table 2: Global HLA Typing for Transplant Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global HLA Typing for Transplant Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global HLA Typing for Transplant Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global HLA Typing for Transplant Market Value (USD Million) By Region

Table 10: Global HLA Typing for Transplant Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global HLA Typing for Transplant Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global HLA Typing for Transplant Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global HLA Typing for Transplant Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Thermo Fischer Scientific Basic Information And Sales Area

Table 31: Thermo Fischer Scientific. Products Portfolio

Table 32: Immucor Basic Information And Sales Area

Table 33: Immucor. Products Portfolio

Table 34: Olerup Basic Information And Sales Area

Table 35: Olerup. Products Portfolio

Table 36: Qiagen Basic Information And Sales Area

Table 37: Qiagen. Products Portfolio

Table 38: Bio-Rad Laboratories Basic Information And Sales Area

Table 39: Bio-Rad Laboratories. Products Portfolio

Table 40: Illumina Basic Information And Sales Area

Table 41: Illumina. Products Portfolio

Table 42: F. Hoffmann-La Roche Basic Information And Sales Area

Table 43: F. Hoffmann-La Roche. Products Portfolio

Table 44: Abbot Laboratories Basic Information And Sales Area

Table 45: Abbot Laboratories. Products Portfolio

Table 46: Luminex Basic Information And Sales Area

Table 47: Luminex. Products Portfolio

Table 48: Global Market Value (USD Million) (2025-2032) By Application

Table 49: Global Market Share (%) By Application (2032)

Table 50: Global Market Value (USD Million) (2025-2032) By Types

Table 51: Global Market Share (%) By Types (2032)

Table 52: Global HLA Typing for Transplant Market Value (USD Million) By Region

Table 53: Global HLA Typing for Transplant Market Share (%) By Region (2025-2032)

Table 54: North America Market Value (USD Million) (2025-2032) By Country

Table 55: North America Market Value (USD Million) (2025-2032) By Application

Table 56: North America Market Value (USD Million) (2025-2032) By Types

Table 57: Europe Market Value (USD Million) (2025-2032) By Country

Table 58: Europe Market Value (USD Million) (2025-2032) By Application

Table 59: Europe Market Value (USD Million) (2025-2032) By Types

Table 60: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 61: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 62: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 63: South America Market Value (USD Million) (2025-2032) By Country

Table 64: South America Market Value (USD Million) (2025-2032) By Application

Table 65: South America Market Value (USD Million) (2025-2032) By Types

Table 66: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 67: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 68: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 69: Research Programs/Design For This Report

Table 70: Key Data Information From Secondary Sources

Table 71: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

HLA Typing for Transplant Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	5.60 billion
Revenue forecast in 2033	10.52 billion
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Thermo Fischer Scientific; Immucor; Olerup; Qiagen; Bio-Rad Laboratories; Illumina; F. Hoffmann-La Roche; Abbot Laboratories; Luminex
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options